Oyogist has learned that Merck & Co Company has announced on Monday that it has applied for emergency use authorization with the U.S. Food and Drug Administration (FDA) for its experimental COVID-19 pill to treat mild-to-moderate COVID-19 patients.
The pill Identified as molnupiravir, prevents the virus from making a copy of itself, which prevents it from spreading throughout the body.
Recent reports also showed that the pill could halve the chances of death or being hospitalized for those most at risk of contracting a severe case of the illness. If authorized, Merck’s drug could be the first oral antiviral medication for the Covid – and could allow patients to take the drug at home instead of going to a hospital.
